Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Aditxt ( (ADTX) ).
On March 27, 2026, Aditxt, Inc. increased the maximum aggregate offering size of its at-the-market common stock program with H.C. Wainwright & Co. by an additional $36.8 million, bringing the potential total under the current authorization to approximately $53.4 million, excluding about $21.3 million of stock already sold. The company also filed a related prospectus supplement and supporting legal opinion, a move that expands its capacity to raise equity capital and may provide additional financial flexibility for operations and strategic priorities, with potential dilution implications for existing shareholders.
More about Aditxt
Aditxt, Inc. operates in the life sciences sector, focusing on the development and commercialization of technologies related to immune system modulation and monitoring. The company is publicly traded and uses capital markets tools, including at-the-market equity programs, to finance its ongoing operations and growth initiatives.
Average Trading Volume: 217,214
Technical Sentiment Signal: Strong Sell
Current Market Cap: $419.5K
Learn more about ADTX stock on TipRanks’ Stock Analysis page.